SCHEMBL5871273

SCHEMBL5871273

OCCc1ccc(CO)c(CO)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.52
BACE1 P56817 2/20 0.52
ALDH1A1 P00352 1/20 0.52
ALOX5 P09917 1/20 0.52
GAA P10253 1/20 0.52
MAPT P10636 1/20 0.52
CA2 P00918 2/20 0.46
TDP1 Q9NUW8 1/20 0.42
VDR P11473 2/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA4 P22748 1/20 0.38
CA6 P23280 1/20 0.38
CA5A P35218 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
CA5B Q9Y2D0 1/20 0.38
TSHR P16473 1/20 0.38
CYP4F2 P78329 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL63352 0.83 BACE1 (0.54) KDM4EBACE1ALDH1A1ALOX5GAA
SCHEMBL63126 0.82 EGFR (0.47) KDM4EMAPTCA2VDRCA12
SCHEMBL29366879 0.82 EGFR (0.47) KDM4EMAPTCA2VDRCA12
SCHEMBL10450798 0.82 KDM4E (0.65) KDM4EBACE1ALDH1A1ALOX5GAA
SCHEMBL15471726 0.82 BACE1 (0.53) KDM4EBACE1ALDH1A1GAAMAPT
SCHEMBL13953779 0.82 CNR1 (0.50) BACE1ALOX5MAPTTDP1VDR
SCHEMBL1244867 0.80 KDM4E (0.47) KDM4EBACE1ALDH1A1ALOX5GAA
SCHEMBL19248504 0.80 BCHE (0.41) KDM4EBACE1ALDH1A1ALOX5GAA
SCHEMBL18199330 0.79 TYR (0.48) KDM4EALDH1A1ALOX5MAPTCA2
SCHEMBL5968356 0.77 VDR (0.37) KDM4EBACE1ALDH1A1ALOX5GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7071201-B2 Serotonin antagonism; muscle relaxant for myotonia; such as 1-(1-(2-(4-methoxyphenyl)ethyl)piperidin-4-yl)-7-methoxy-1,2,3,4 -tetrahydroquinoline EISAI CO., LTD. (JP) 2006-07-04 US disclosed
CN-1204121-C 1,4-substituted cyclic amine derivatives EISAI CO LTD (JP) 2005-06-01 CN disclosed
EP-0976732-B1 1,4-SUBSTITUTED CYCLIC AMINE DERIVATIVES EISAI CO LTD (JP) 2004-11-24 EP disclosed
US-6579881-B2 Indoles EISAI CO., LTD. (JP) 2003-06-17 US disclosed
US-6448243-B1 SEROTONIN ANTAGONIST FOR TREATING, AMELIORATING AND PREVENTING SPASTIC PARALYSIS OR CENTRAL MUSCLE RELAXANTS FOR AMELIORATING MYOTONIA EISAI CO., LTD. (JP) 2002-09-10 US disclosed
US-20020086999-A1 Certain quinoline derivatives EISAI CO., LTD. 2002-07-04 US disclosed
US-20020019531-A1 Indoles EISAI CO., LTD. 2002-02-14 US disclosed
CN-1253547-A 1,4-substituted cyclic amine derivatives EISAI CO LTD (JP) 2000-05-17 CN disclosed
EP-0976732-A1 1,4-SUBSTITUTED CYCLIC AMINE DERIVATIVES Eisai Co., Ltd. (JP) 2000-02-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019531-A1 Indoles INMT, MUSK, MB KDM4E 927/4885BACE1 4259/4885ALDH1A1 3599/4885
US-20020086999-A1 Certain quinoline derivatives CHRM1, CHRNA5, CHRNA4 KDM4E 1127/4885BACE1 3717/4885ALDH1A1 3941/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.